Powder: -20°C for 3 years | In solvent: -80°C for 1 year
EB-0150 is a potent inhibitor of ER α-glucosidase (α-Glu) I (IC50s: 0.73 μM) and (α-Glu) II (IC50s: 0.0337 μM). EB-0150 is an N-substituted valerian derivative with broad-spectrum antiviral effects. EB-0150 has potential for broad-spectrum drug discovery against existing and emerging viruses. It has potential for research.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,520.00 | |
50 mg | 10-14 weeks | $ 1,980.00 | |
100 mg | 10-14 weeks | $ 2,500.00 |
Description | EB-0150 is a potent inhibitor of ER α-glucosidase (α-Glu) I (IC50s: 0.73 μM) and (α-Glu) II (IC50s: 0.0337 μM). EB-0150 is an N-substituted valerian derivative with broad-spectrum antiviral effects. EB-0150 has potential for broad-spectrum drug discovery against existing and emerging viruses. It has potential for research. |
Molecular Weight | 454.48 |
Formula | C19H30N6O7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.